Abbvie Biotechnology Ltd

Tap Pharmaceutical Products Inc.

Abb Holdings, Inc.

Renee J Perdok

Dustin D Ruff

Rebecca S Hoffman

Christopher T Ritchlin

John R Medich

Robert L Wong

Eric H Sasso

Karen Kling

Phillip Mease

The invention provides methods, uses and compositions for the treatment of psoriatic arthritis. The invention describes methods and uses for treating psoriatic arthritis, wherein a TNF&#x3b1; inhibitor, such as a human TNF&#x3b1; antibody, or antigen-binding portion thereof, is used to psoriatic arthritis in a subject. Also described are methods for determining the efficacy of a TNF&#x3b1; inhibitor for treatment of psoriatic arthritis in a subject.

Uses and compositions for treatment of psoriatic arthritis

A method for treating sexual dysfunction that is caused by anti-depressant medication in a patient in need of such treatment, comprising administering a therapeutically effective amount of apomorphine, or a pharmaceutically acceptable salt thereof to said patient, is disclosed. The method may be utilized for patients taking anti-depressants such as tricyclic anti-depressants, monamine oxidase inhibitors or serotonin selective reuptake inhibitors.

Treatment of anti-depression drug-induced sexual dysfunction with apomorphine

A method of treating organic erectile dysfunction, particularly vasculogenic erectile dysfunction comprises administering to a male in need of such treatment a therapeutically effective amount of apomorphine or a pharmaceutically acceptable salt or pro-drug thereof.

Use of apomorphine for the treatment of organic erectile dysfunction in males

Growing community of inventors

Gurnee, IL, United States of America

Renee J Perdok